Detalhe da pesquisa
1.
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
Vaccines (Basel)
; 11(3)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992257
2.
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.
NPJ Vaccines
; 8(1): 45, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949051
3.
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine
; 40(6): 934-944, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973849